Hosted on MSN1mon
Lantheus' Pylarify Hit $1B in 2024 SalesProstate imaging drug Pylarify has become the first radiodiagnostic ... a registrational stage PET radiodiagnostic that would complement Lantheus' therapeutic candidate, PNT2003.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback